GAPDH antibody (AA 1-335)

Catalog No. ABIN934059

This anti-GAPDH antibody is a Mouse Monoclonal antibody detecting GAPDH in WB, ELISA and IF. Suitable for Human. This Primary Antibody has been cited in 9+ publications.

Quick Overview for GAPDH antibody (AA 1-335) (ABIN934059)

Target: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This GAPDH antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Clone: AT8G4

Product Details anti-GAPDH Antibody

Binding Specificity: AA 1-335

Purification: GAPDH antibody was purified by protein-G affinity chromatography

Immunogen: GAPDH antibody was raised in mouse using recombinant human GAPDH (1-335aa) purified from E.coli as the immunogen.

Isotype: IgG2b kappa

Application Details

Application Notes: IF: 1:500-1:10,00, WB: 1:500-1:10,000

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: as a liquid PBS, pH 7.4, with 0.1 % NaN3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freeze/thaw cycles

Storage: -20 °C

Storage Comment: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

References for anti-GAPDH antibody (ABIN934059)

Stewart, Ma, Megison, Nabers, Cance, Kurenova, Beierle: "Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma." in: Molecular carcinogenesis, Vol. 54, Issue 1, pp. 9-23, (2015) (PubMed).

Gillory, Megison, Stewart, Mroczek-Musulman, Nabers, Waters, Kelly, Coleman, Markert, Gillespie, Friedman, Beierle: "Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma." in: PLoS ONE, Vol. 8, Issue 10, pp. e77753, (2013) (PubMed).

Wright, Wu, Dahl, Sazama, OConnell: "Nuclear localization drives ?1-adrenergic receptor oligomerization and signaling in cardiac myocytes." in: Cellular signalling, Vol. 24, Issue 3, pp. 794-802, (2012) (PubMed).

Kuroda, Ishii, Uematsu, Ohata, Coban, Akira, Aritake, Urade, Morimoto: "Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms." in: Immunity, Vol. 34, Issue 4, pp. 514-26, (2011) (PubMed).

Shi, Zhang, Yang, Zhang, Wei: "ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice." in: Journal of molecular and cellular cardiology, Vol. 49, Issue 5, pp. 819-28, (2010) (PubMed).

Heineke, Wollert, Osinska, Sargent, York, Robbins, Molkentin: "Calcineurin protects the heart in a murine model of dilated cardiomyopathy." in: Journal of molecular and cellular cardiology, Vol. 48, Issue 6, pp. 1080-7, (2010) (PubMed).

Wang, Hirschberg: "Diabetes-relevant regulation of cultured blood outgrowth endothelial cells." in: Microvascular research, Vol. 78, Issue 2, pp. 174-9, (2009) (PubMed).

Aligo, Jia, Manna, Konan: "Formation and function of hepatitis C virus replication complexes require residues in the carboxy-terminal domain of NS4B protein." in: Virology, Vol. 393, Issue 1, pp. 68-83, (2009) (PubMed).

von Hattingberg, Brockmeier: "The pharmacokinetic basis of optimal antibiotic dosage." in: Infection, Vol. Suppl 1, pp. 21-4, (1980) (PubMed).

Target Details for GAPDH

Target: GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH))

Alternative Name: GAPDH